Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026PLoS ONEOpen Access

Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKathryn HirabayashiVLVitaly LormanSWShannon Wuller

Discussion

Loading...

Member takes

Overview

Retrospective cohort study evaluates steroid effectiveness in preventing long COVID in children, suggesting limited impact.

Key Points

  • Evaluate the effectiveness of steroids in preventing long COVID in children during acute SARS-CoV-2 infection.
  • Retrospective cohort study using target trial emulation methodology.
  • Compared children receiving steroids to those who did not within 12 days of SARS-CoV-2 infection.
  • Analyzed primary and secondary outcomes using Cox proportional models.
  • In hospitalized children, steroid use reduced the risk of gastrointestinal PASC (HR: 0.58; 95% CI: 0.39–0.85, p=0.01).
  • No significant impact of steroid treatment on other PASC outcomes in hospitalized patients or outpatients.
  • Overall, steroids did not lead to a decreased risk of long COVID except for gastrointestinal issues.

Cite This Study

Hirabayashi et al. (2026) studied this question.

synapsesocial.com/papers/6a362f92db0793dc1a536f3dhttps://doi.org/10.1371/journal.pone.0350888
View Full Paper
Ask AI
Bookmark
Share